Investigational drug · Phase 2
BCB-276
Not approved by FDA. In 1 industry-sponsored Phase 2 or 3 trial that is active or finished in the last two years, most often for Diffuse Intrinsic Pontine Glioma, DIPG, Brain Tumor.
Phase 2Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations
Highest phase
Phase 2
Industry-sponsored trials
Phase 2 and 3 trials
1
1 still active
All registered trials
1
Any phase or sponsor naming "BCB-276"
First trial start
2026
Sep 4, 2026
Sponsors
Lead sponsors of its Phase 2 and 3 trials.
All registered trials by phase
Every ClinicalTrials.gov drug study naming "BCB-276", any sponsor or status.
Conditions studied
As listed on its trial records.
- Diffuse Intrinsic Pontine Glioma
- DIPG
- Brain Tumor
- CNS Tumor
- Central Nervous System Tumor
- Pediatric Cancer
- Adult Cancer Patients
- CNS Tumor, Childhood
- CNS Tumor, Adult
- Brainstem Glioma
Approved drugs for the same conditions: Brain tumors (glioma) · Oncology
Largest trials
Live from ClinicalTrials.gov: studies naming "BCB-276" as an intervention, largest first.
- Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).Pivotal-lookingRecruiting
BrainChild Bio, IncIndustry
NCT07680439 · 75 participants (planned) · Start Sep 4, 2026 · Primary completion Oct 2028
Drug: BCB-276 · For: Diffuse Intrinsic Pontine Glioma; DIPG; Brain Tumor and 9 more
Sites: Los Angeles, California; Atlanta, Georgia; Chicago, Illinois · 6 sites in all
Newest research
PubMed records naming it or its code names, newest first.
No PubMed records name it yet, which is common for early code-named drugs.
Also in development for Diffuse Intrinsic Pontine Glioma
- VRT106Phase 33 trials
Guangzhou Virotech Pharmaceutical Co., Ltd. · Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Intrinsic Pontine Glioma, HCC
Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.